Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Rivaroxaban may cause hair loss.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.